C. Difficile
Study Protocol
A randomized, doubled-blind, placebo-controlled phase 3 study of vesos for prevention of Clostridioides Difficile Infection
Study Duration
48 WEEKS
INCLUSION CRITERIA
- Age ≥12 years
- History of CDI 6-12 months prior
- Immunosuppressive therapy or disease
- Solid organ or hematopoietic stem cell transplant